FR2635007A1 - Therapeutic method reestablishing the balance of the magnetic field surrounding the human body - Google Patents
Therapeutic method reestablishing the balance of the magnetic field surrounding the human body Download PDFInfo
- Publication number
- FR2635007A1 FR2635007A1 FR8810550A FR8810550A FR2635007A1 FR 2635007 A1 FR2635007 A1 FR 2635007A1 FR 8810550 A FR8810550 A FR 8810550A FR 8810550 A FR8810550 A FR 8810550A FR 2635007 A1 FR2635007 A1 FR 2635007A1
- Authority
- FR
- France
- Prior art keywords
- cabbage
- jar
- liquid
- magnetic field
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
DESCRIPTION
Titre de l'invention
Procédé thérapeutique rétablissant l'équilibre du champ magnétique, entourant le corps humain.DESCRIPTION
Title of invention
Therapeutic process restoring the balance of the magnetic field surrounding the human body.
Domaine technioue de l'invention
Laboratoires pharmaceutiques
Medecine générale
Etat de la technique antérieure.faisant ressortir le problème technique posé
A notre connaissance,les problèmes de santé,n'ont jamais été traité de la façon dont nous l'envisageons. La médecine traite maladie par maladie,supprimant des effets et non des causes,comme notre procédé qui soigne tout le corps dans son ensemhlepuisque l'équilibre du champ magnéti- que est indispensable à une bonne santé,et une bonne résistance à toutes attaques externes et internes,de virus en particulier.D'autre part,notre composant principal comme agent de radiations,le chou,n'existe pas dans la pharmacopée francaise ou en son formulaire national,en tant que principe actif.Technical field of the invention
Pharmaceutical laboratories
General medicine
State of the prior art bringing out the technical problem posed
To our knowledge, health problems have never been treated the way we see it. Medicine treats disease by disease, removing effects and not causes, like our process which heals the whole body in its entirety since the balance of the magnetic field is essential for good health, and good resistance to all external attacks and On the other hand, our main component as a radiation agent, cabbage, does not exist in the French Pharmacopoeia or in its national form, as an active ingredient.
Exposé de l'invention, dégageant la solution apportée par l'invention
Composition produit prêt à l'emploi/émetteur radiations extrait liquide de chou milan 25% extrait liquide de chou cabus 25% eau de source(minéralisation totale en mg/I 3I9-PH 7,4
calcium ca ++B8-magnsium mg ++8-sodium na+6-potas
sium k+I-bicarbonate co3H 248-sulfate so4 4I-chloru
re CI I2-nitrate no3 0,I ) portant extraits.Statement of the invention, identifying the solution provided by the invention
Composition ready-to-use product / radiation emitter kale liquid extract 25% cabbage cabbage liquid extract 25% spring water (total mineralization in mg / I 3I9-PH 7.4
calcium ca ++ B8-magnsium mg ++ 8-sodium na + 6-potas
sium k + I-bicarbonate co3H 248-sulfate so4 4I-chloru
re CI I2-nitrate no3 0, I) carrying extracts.
excipient huile de soja 50%
Conditionnement en flacon I0cl ode d'action
Le produit émet en permanence,tout en demeurant stable et ne s'usant pas,des radiations equilibrantes,agissant directement sur le champ magnétique entourant le -orps. excipient soy oil 50%
Packaging in I0cl bottle action mode
The product emits permanently, while remaining stable and not wearing, equilibrating radiation, acting directly on the magnetic field surrounding the body.
Moe d'emploi
a) flacon ferm à laisser auprès du malade,toute la matinée.Moe job
a) closed bottle to leave with the patient, all morning.
b)secouer le flacon pour émulsion extrait/excipient; tendre un peu de l'émulsion sur peau du malade à l' aplomb du mal ou autour,ou si affection non localisée ou généralisée, sur le front(la peau du malade,n'est que le support du produit et pour qu'il soit au contact avec le champ magnétique) Node de fabrication
Uniquement dans l'hémisphére nord de la Terre le 10 Avril hachage chou milan,remplir avec les 2/3 un bocal en verre,compléter avec eau de source,fermeture hermétique du bocal,laisser bocal à l'air libre du II Avril au 20 Mai(40 joursx24h)Le 2I Mai ouverture bo- cal,filtrage liquide,rejet matière,puis hachage chou cabus.Remplir bocal verre au 2/3 ce chou hache.Completer
ave liquide filtré issu chou milan,fermeture hermeti
que bocal. Laisssr à l'air libre du 22 Mai au 20 Juin( 30 joursx24h)A partir du 21 Juin filtrage liquide,rejet matière la suite conditionnement 50% extrait +50% excipient huile de soja.Stockage abri lumière du jour et artificielle. Bocaux pour fabrication massive,préférable multiple ou sous multiple de 9m3.b) shake the bottle for extract / excipient emulsion; stretch a little of the emulsion on the patient's skin plumb with or around the pain, or if not localized or generalized, on the forehead (the patient's skin is only the support of the product and so that it either in contact with the magnetic field) Manufacturing node
Only in the northern hemisphere of the Earth on April 10, chopping kale, fill with 2/3 a glass jar, fill with spring water, seal the jar, leave the jar in the open air from April II to 20 May (40 joursx24h) Le 2I Mai can opening, liquid filtering, material rejection, then chopping cabbage cabbage. Fill glass jar with 2/3 this chopped cabbage.
with filtered liquid from milan cabbage, airtight closure
that jar. Leave in the open air from May 22 to June 20 (30 daysx24h) From June 21 liquid filtration, material rejection following packaging 50% extract + 50% soybean oil excipient. Storage under daylight and artificial shelter. Jars for mass production, preferable multiple or sub-multiple of 9m3.
Indication de la manière dont l'invention est susceptible, d'applications industielles
Fabrication par tous Laboratoires Pharmaceutiques de l'émisphère nord,dans la mesure ou gelées terminées le 10 Avril.Indication of how the invention is susceptible of industrial applications
Manufactured by all Pharmaceutical Laboratories in the northern emisphere, to the extent that jellies ended on April 10.
Utilisation en médecine générale.Use in general medicine.
Des essais de guérison (en quelques minutes,heures,maxi 15 jours ont été concluants pour:fongus-phlegmon-anth- rax-panaris-furoncles-urticaire-plaie-blessures-ulcères névralgie faciale-névralgie dentaire-céphalée-abcés den- taire-migraine-rhumatisme-affection intestinale-hémoroï- de-excitation nerveuse-insomnie-dépression-
devrait être aussi efficace pour variole-roureole- scarlatine-zona-pustules-acné-eczéma-dartres-érysipèle maladie des vaisseaux sanguins-nécrose-gangréne-syphi- llis-ulcération-gerçures-typhoïde-fievre puerpuralesciatique-goutte-diabete-hystérie-catalepsie-épilepsie corysa-bronchite-aphonie-surdité-asthme-tumeurs blanches-engorgement glandulaire-engelures-...et surtout:
Cancers et Sida Healing trials (in a few minutes, hours, maximum 15 days have been conclusive for: fungus-phlegmon-anthrax-panaris-boils-urticaria-wound-wounds-ulcers facial neuralgia-dental neuralgia-headache-dental abscesses -migraine-rheumatism-intestinal disease-hemoroï-of-nervous excitement-insomnia-depression-
should also be effective for smallpox-roureole-scarlet fever-shingles-pustules-acne-eczema-dartres-erysipelas disease of the blood vessels-necrosis-gangrene-syphi- llis-ulceration-cracks-typhoid-puerpural fever-gout-diabetes-hysteria- catalepsy-corysa epilepsy-bronchitis-aphonia-deafness-asthma-white tumors-glandular engorgement-frostbite -... and especially:
Cancers and AIDS
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8810550A FR2635007B1 (en) | 1988-08-04 | 1988-08-04 | THERAPEUTIC PROCESS RE-ESTABLISHING THE BALANCE OF THE MAGNETIC FIELD SURROUNDING THE HUMAN BODY |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8810550A FR2635007B1 (en) | 1988-08-04 | 1988-08-04 | THERAPEUTIC PROCESS RE-ESTABLISHING THE BALANCE OF THE MAGNETIC FIELD SURROUNDING THE HUMAN BODY |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2635007A1 true FR2635007A1 (en) | 1990-02-09 |
FR2635007B1 FR2635007B1 (en) | 1991-05-10 |
Family
ID=9369114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8810550A Expired - Lifetime FR2635007B1 (en) | 1988-08-04 | 1988-08-04 | THERAPEUTIC PROCESS RE-ESTABLISHING THE BALANCE OF THE MAGNETIC FIELD SURROUNDING THE HUMAN BODY |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2635007B1 (en) |
-
1988
- 1988-08-04 FR FR8810550A patent/FR2635007B1/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
R.F. WEISS: "Herbal Medicine", 1988, pages 61-62, AB Arcanum & Beaconsfield Publishers Ltd, Beaconsfield, GB * |
Also Published As
Publication number | Publication date |
---|---|
FR2635007B1 (en) | 1991-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9702362A (en) | New stable liquid formulas based on paracetamol and its preparation. | |
ATE237339T1 (en) | USE OF MODIFIED OWN BLOOD TO TREAT AUTOIMMUNE DISEASES | |
DE3684190D1 (en) | USE OF TETRAHYDROBIOPTERINES FOR PRODUCING A MEDICINE FOR TREATING CHILDREN'S AUTISM. | |
JPH09157176A (en) | Antiallergic agent containing extract of hypericum erectum thunb. and tilia miqueliana maxim. | |
JPH09110710A (en) | Dermal preparation for external use and bathing agent | |
DE69602412D1 (en) | Ophthalmic preparation for the treatment or prevention of dry eye and diseases caused thereby, containing 12-sulfodehydroabietic acid | |
ES2073425T3 (en) | A NEW GLYCOPROTEIN OF THE THROMBOMODULIN TYPE SUSCEPTIBLE TO BE OBTAINED FROM THE URINE. | |
DE69025271D1 (en) | Delayed release pharmaceutical preparations for the treatment of periodontal diseases | |
CA1173359A (en) | Antigenic material | |
FR2635007A1 (en) | Therapeutic method reestablishing the balance of the magnetic field surrounding the human body | |
RO120121B1 (en) | Injectable solution having antiinflammatory effect, process for preparing the same and method for treating autoimmune diseases | |
DE3776561D1 (en) | USE OF PETASITES EXTRACTS FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING GASTROINTESTINAL DISEASES. | |
US20180110809A1 (en) | Bioassimilable protein-melanin complex, preparation and uses | |
Noguchi | Action of certain biological, chemical, and physical agents upon cultures of Leishmania: some observations on plant and insect Herpetomonads | |
US5980903A (en) | Composition for the treatment of viral infections including HIV | |
DE3853427D1 (en) | TREATING AGED SKIN WITH ORAL 13-CIS RETINIC ACID. | |
EP1284596A4 (en) | APPARATUS AND PROCESS FOR i IN SITU /i MANUFACTURE OF ESSENCE FROM LIVING, UNCUT PLANTS | |
PT93813A (en) | PROCESS FOR THE PREPARATION OF A PRODUCT FOR THE TREATMENT OF THE NAILS, SKIN AND HAIR CONTAINING TRIGONELINE AND VITAMIN B6 | |
Kamal et al. | Snake bite, venom, anti-venom production and anti-venom activity of medicinal plants: a review | |
Sachedina et al. | Wild aloe harvesting in South Africa | |
JPS5531001A (en) | Preparation of beauty wash composed of natural lemon and pure honey | |
DE3786173D1 (en) | HUMAN MONOCLONAL ANTIBODY AND MEDICINES FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS DISEASES. | |
CN1063048C (en) | Water soluble pearl powder and its processing technique | |
Sun et al. | Effect of selenium in recovery of immunity damaged by H 2 O 2 and 60 Co radiation | |
ATE66815T1 (en) | MEDICATION CONTAINING AN ORGAN EXTRACT PRODUCED FROM PEYER'S PLAQUES FOR THE TREATMENT OF DIABETES MELLITUS AND PANCREATITIS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |